Correct me if I'm wrong - but isn't dose level 2 - patients 4, 5 and six in this trial? If so, didn't I read that they won't release data until after patient six is dosed?
Considering they've only dosed one patient at this dose level, any trial data would be a while off?
Patient 5 had their manufacturing run way back in February so I'm concerned about the delay in them being dosed.
Anyone able to assist?
Correct me if I'm wrong - but isn't dose level 2 - patients 4, 5...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $28.14K | 7.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 243067 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14771167 | 22 |
View Market Depth
| Last trade - 15.39pm 20/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |